About
TMClear is a privately held biotech company developing next generation therapies for ophthalmology, including novel drug candidates for wide-angle glaucoma and neuro-protective treatments in collaboration with the University of Utah.
Explore TMClear's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.